Drugs / Qiling Yiqi Tablets
Qiling Yiqi Tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07698574 | Aug 2026 → Feb 2028 expected | AIDS, splenomegaly syndrome with splenic Germinal center hypoplasia and reduced circulating T helper cells | Beijing University of Chinese Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qiling Yiqi Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07698574 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Qiling Yiqi Tablets are a marketed Chinese patent medicine” NCT07698574 ↗ |
| Route | Oral | “Dose: 6 tablets orally three times daily after meals with warm water for 48 weeks.” NCT07698574 ↗ |